Pirfenidone Applications: Beyond IPF Treatment
Pirfenidone (CAS: 53179-13-8) is a well-established pharmaceutical intermediate, primarily known for its critical role in managing Idiopathic Pulmonary Fibrosis (IPF). However, the therapeutic potential of this compound, thanks to its potent antifibrotic and anti-inflammatory properties, is increasingly being recognized across a wider range of fibrotic interstitial lung diseases (FILDs). For R&D scientists and pharmaceutical procurement managers, understanding these broader applications is key to sourcing this valuable intermediate. NINGBO INNO PHARMCHEM CO.,LTD., a leading manufacturer and supplier of pharmaceutical chemicals in China, is at the forefront of providing high-quality Pirfenidone for diverse research and therapeutic needs.
While IPF remains its primary indication, research is continuously uncovering the benefits of Pirfenidone in other conditions characterized by progressive lung scarring. These include fibrotic lung diseases associated with connective tissue disorders, environmental exposures, and even post-viral lung damage such as that seen in some COVID-19 survivors. The compound’s ability to inhibit key fibrotic pathways and inflammatory responses makes it a promising candidate for slowing disease progression and improving patient outcomes in these varied conditions. This expanding scope of application underscores the importance of a reliable Pirfenidone manufacturer.
As a global supplier, NINGBO INNO PHARMCHEM CO.,LTD. offers pharmaceutical-grade Pirfenidone, ensuring the purity and consistency required for both clinical trials and commercial drug production. Our commitment to quality means that researchers and manufacturers can confidently buy Pirfenidone from us, knowing they are obtaining a product that meets rigorous standards. We cater to various needs, from small quantities for early-stage research to bulk orders for large-scale manufacturing, always with a focus on competitive pricing and dependable supply.
The exploration of Pirfenidone in new therapeutic areas signifies its potential as a versatile pharmaceutical intermediate. Pharmaceutical companies looking to develop novel antifibrotic therapies or expand their product lines will find Pirfenidone to be an essential component. NINGBO INNO PHARMCHEM CO.,LTD. is your trusted partner in this endeavor, providing the essential chemical building blocks needed to advance medical science. We encourage R&D professionals and procurement specialists to connect with us to learn more about our Pirfenidone offerings and how we can support your critical projects.
Perspectives & Insights
Molecule Vision 7
“is your trusted partner in this endeavor, providing the essential chemical building blocks needed to advance medical science.”
Alpha Origin 24
“We encourage R&D professionals and procurement specialists to connect with us to learn more about our Pirfenidone offerings and how we can support your critical projects.”
Future Analyst X
“Pirfenidone (CAS: 53179-13-8) is a well-established pharmaceutical intermediate, primarily known for its critical role in managing Idiopathic Pulmonary Fibrosis (IPF).”